The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Pedder Simon since year 2005.
The trader's CIK number is 1316736.
At the time of this reporting, Pedder Simon is the President and CEO of Cellectar Biosciences, Inc. .
(stock ticker symbol CLRB).
See this page for all insider trading activities at Cellectar Biosciences, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-08-20||CLRB||Cellectar Biosciences, Inc.||Buy||13,300||3.75||49,875|
|2010-09-02||CHTP||Chelsea Therapeutics International, Ltd.||Buy||1,250||4.08||5,100|
|2009-12-17||CHTP||Chelsea Therapeutics International, Ltd.||Buy||4,600||2.20||10,120|
|2008-09-24||CHTP||Chelsea Therapeutics International, Ltd.||Buy||3,000||2.90||8,700|
|2006-08-23||CHTP.OB||Chelsea Therapeutics International, Ltd.||Buy||1,000||3.27||3,267|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pedder Simon (President and CEO of Cellectar Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.